FDA Import Refusal 799-1109746-0/10003/1 — NOVO NORDISK
The FDA refused shipment 799-1109746-0/10003/1 from NOVO NORDISK (Canada) on Aug 31, 2026. The refused product falls under Drugs and Biologics — SEMAGLUTIDE (ANTI-DIABETIC). Cited charge: 9999985 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Aug 31, 2026
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 61PCL72 SEMAGLUTIDE (ANTI-DIABETIC)
- Charges
- 9999985